Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality

Conclusion Intensive combined breast cancer screening with annual MRI and mammography appears to improve survival from breast cancer in BRCA2 mutation carriers. Data from larger groups are required to confirm the effectiveness of combined screening in BRCA2 carriers.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research